Obstructive urination problems after high-dose-rate brachytherapy boost treatment for prostate cancer are avoidable

Abstract

Aiming at improving treatment individualization in patients with prostate cancer treated with combination of external beam radiotherapy and high-dose-rate brachytherapy to boost the dose to prostate (HDRB-B), the objective was to evaluate factors that have potential impact on obstructive urination problems (OUP) after HDRB-B.

Keywords

• prostate cancer
• high-dose-rate brachytherapy boost
• late effects
• urinary stricture
• obstructive urination problems